Abstract
Purpose
The role of postoperative irradiation to contralateral non-involved neck nodes in lateralized carcinoma of the head and neck is not clear. The contralateral neck failure rate in head and neck carcinoma treated postoperatively with ipsilateral neck irradiation only was evaluated.
Methods
Patients with carcinoma of the oral cavity, oropharynx, or hypopharynx without midline extension treated between 1990 and 2016 were analyzed. After tumor resection and neck dissection (ND), radiotherapy was given to the primary tumor site and ipsilateral neck. High-risk patients additionally received concurrent chemotherapy. Freedom from contralateral neck recurrence (FCNR), locoregional control rate (LRC), overall survival (OS), and disease-free survival (DFS) were evaluated.
Results
197 patients (median age 60.7 years, 66.5% males, 52.8% oropharyngeal carcinomas) were analyzed. Complete resection (R0) was achieved in 85.8% of cases. Ipsilateral ND was performed in all patients and contralateral ND in 144 patients (73.1%). Concurrent chemotherapy was given to 59 patients (30.0%). After a median follow-up of 45.5 months, OS and DFS of all patients were 73.6% and 70.9% at 5 years, respectively. A total of 45 patients (22.8%) suffered from a locoregional recurrence, lymph node metastases of the contralateral neck developed in 12 patients (6.1%) only. There was no significant difference in contralateral nodal failure rate with or without performance of contralateral ND.
Conclusion
Regional failure of the contralateral neck was low after surgery and ipsilateral neck irradiation in head and neck carcinomas without midline extension, supporting evidence that contralateral neck radiotherapy can safely be omitted in selected cases.
Similar content being viewed by others
References
Jackson SM, Hay JH, Flores AD et al (1999) Cancer of the tonsil: the results of ipsilateral radiation treatment. Radiother Oncol 51:123–128. https://doi.org/10.1016/S0167-8140(99)00051-1
O’Sullivan B, Warde P, Grice B et al (2001) The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol 51:332–343. https://doi.org/10.1016/S0360-3016(01)01613-3
Vergeer MR, Doornaert PAH, Jonkman A et al (2010) Ipsilateral irradiation for oral and oropharyngeal carcinoma treated with primary surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 78:682–688. https://doi.org/10.1016/j.ijrobp.2009.08.042
Rusthoven KE, Raben D, Schneider C et al (2009) Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach. Int J Radiat Oncol Biol Phys 74:1365–1370. https://doi.org/10.1016/j.ijrobp.2008.10.023
Chronowski GM, Garden AS, Morrison WH et al (2012) Unilateral radiotherapy for the treatment of tonsil cancer. Int J Radiat Oncol Biol Phys 83:204–209. https://doi.org/10.1016/j.ijrobp.2011.06.1975
Chin R‑I, Rao YJ, Hwang MY et al (2017) Comparison of unilateral versus bilateral intensity-modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil. Cancer 123:4594–4607. https://doi.org/10.1002/cncr.30931
Jensen K, Overgaard M, Grau C (2007) Morbidity after ipsilateral radiotherapy for oropharyngeal cancer. Radiother Oncol 85:90–97. https://doi.org/10.1016/j.radonc.2007.06.005
Quon H, Vapiwala N, Forastiere A et al (2017) Radiation therapy for oropharyngeal squamous cell carcinoma: American society of clinical oncology endorsement of the American society for radiation oncology evidence-based clinical practice guideline. J Clin Oncol 35:4078–4090. https://doi.org/10.1200/JCO.2017.73.8633
Dan TD, Raben D, Schneider CJ et al (2015) Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: updated results of an institutional clinical management approach. Oral Oncol 51:616–621. https://doi.org/10.1016/j.oraloncology.2015.03.013
Olzowy B, Tsalemchuk Y, Schotten K‑J et al (2011) Frequency of bilateral cervical metastases in oropharyngeal squamous cell carcinoma: a retrospective analysis of 352 cases after bilateral neck dissection. Head Neck 33:239–243. https://doi.org/10.1002/hed.21436
Lim YC, Lee SY, Lim J‑Y et al (2005) Management of contralateral N0 neck in tonsillar squamous cell carcinoma. Laryngoscope 115:1672–1675. https://doi.org/10.1097/01.mlg.0000184791.68804.0b
Yeung AR, Garg MK, Lawson J et al (2012) ACR appropriateness criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil. Head Neck 34:613–616. https://doi.org/10.1002/hed.21993
Govers TM, de Kort TBH, Merkx MAW et al (2016) An international comparison of the management of the neck in early oral squamous cell carcinoma in the Netherlands, UK, and USA. J Craniomaxillofac Surg 44:62–69. https://doi.org/10.1016/j.jcms.2015.10.023
D’Cruz AK, Vaish R, Kapre N et al (2015) Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med 373:521–529. https://doi.org/10.1056/NEJMoa1506007
Schilling C, Stoeckli SJ, Haerle SK et al (2015) Sentinel European Node Trial (SENT): 3‑year results of sentinel node biopsy in oral cancer. Eur J Cancer 51:2777–2784. https://doi.org/10.1016/j.ejca.2015.08.023
Mehanna H, Wong W‑L, McConkey CC et al (2016) PET-CT surveillance versus neck dissection in advanced head and neck cancer. N Eng J Med. https://doi.org/10.1056/NEJMoa1514493
Contreras JA, Spencer C, DeWees T et al (2019) Eliminating postoperative radiation to the pathologically node-negative neck: long-term results of a prospective phase II study. J Clin Oncol 37:2548–2555. https://doi.org/10.1200/JCO.19.00186
Al-Mamgani A, van Rooij P, Fransen D, Levendag P (2013) Unilateral neck irradiation for well-lateralized oropharyngeal cancer. Radiother Oncol 106:69–73. https://doi.org/10.1016/j.radonc.2012.12.006
Koo TR, Wu H‑G (2013) Long-term results of ipsilateral radiotherapy for tonsil cancer. Radiat Oncol J 31:66–71. https://doi.org/10.3857/roj.2013.31.2.66
Al-Mamgani A, van Werkhoven E, Navran A et al (2017) Contralateral regional recurrence after elective unilateral neck irradiation in oropharyngeal carcinoma: a literature-based critical review. Cancer Treat Rev 59:102–108. https://doi.org/10.1016/j.ctrv.2017.07.004
Werner JA, Dünne AA, Myers JN (2003) Functional anatomy of the lymphatic drainage system of the upper aerodigestive tract and its role in metastasis of squamous cell carcinoma. Head Neck 25:322–332. https://doi.org/10.1002/hed.10257
Lindberg R (1972) Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 29:1446–1449. https://doi.org/10.1002/1097-0142(197206)29:6〈1446::AID-CNCR2820290604〉3.0.CO;2‑C
Grégoire V, Grau C, Lapeyre M, Maingon P (2018) Target volume selection and delineation (T and N) for primary radiation treatment of oral cavity, oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma. Oral Oncol 87:131–137. https://doi.org/10.1016/j.oraloncology.2018.10.034
De-Intensification Radiotherapy Postoperative Head Neck—Full Text View—ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02528955. Accessed 28 Dec 2017
Koyfman SA, Ismaila N, Crook D et al (2019) Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline. J Clin Oncol:1801921. https://doi.org/10.1200/JCO.18.01921
Rackley TP, Namelo WC, Palaniappan N, Cole N, Owens DMJ, Evans M, (2017) Unilateral radiotherapy for surgically resected lateralized squamous cell carcinoma of the tonsil. Head Neck 39 (1):17–23
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
M.M. Wirtz, S. Temming, M. Kocher, S. Kunze, and R. Semrau declare that they have no competing interests.
Additional information
Mirja M. Wirtz and Susanne Temming share first authorship.
Rights and permissions
About this article
Cite this article
Wirtz, M.M., Temming, S., Kocher, M. et al. Low risk of contralateral lymph node recurrence in lateralized head and neck carcinoma after postoperative ipsilateral radiotherapy. Strahlenther Onkol 196, 474–484 (2020). https://doi.org/10.1007/s00066-019-01556-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-019-01556-0